Worldwide burden of liver cancer due to metabolic dysfunction-associated steatohepatitis from 1990 to 2019: insights from the Global Burden of Disease study
The burden of MASH-related HCC is expected to rise slightly over the next decade. This disease, which is not associated with the SDI, remains a major public health problem. In addition, the escalating rates of obesity, demographic shifts, and an aging population could position MASH as a leading factor in liver cancer cases, surpassing viral hepatitis. It is imperative, therefore, that the forthcoming years see the implementation of strategic interventions aimed at the early detection and prevention of liver cancer associated with MASH.
Authors
- Xianmei Wang (ORCID: https://orcid.org/0000-0002-6273-3096)
- Dan Zhang (ORCID: https://orcid.org/0000-0002-6133-8318)
- Yu Li (ORCID: https://orcid.org/0000-0001-6910-5933)
- Hang Chen (ORCID: https://orcid.org/0000-0003-1410-4284)
- Hui Wang (ORCID: https://orcid.org/0000-0002-7639-5702)
- Mengwei Li (ORCID: https://orcid.org/0000-0002-8513-9014)
- Qingqing Zhou (ORCID: https://orcid.org/0000-0001-9224-0914)
- Da Wang (ORCID: https://orcid.org/0000-0003-1189-4663)
- Lanqing Ma (ORCID: https://orcid.org/0000-0002-9738-9934)
- Minshan Huang
Institutions
- Kunming Medical University (CN)
- First Affiliated Hospital of Kunming Medical University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-08-29
- DOI
- https://doi.org/10.3389/fonc.2024.1424155
- Citations
- 8
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.09